Inventor

Scott Koenig

Inventor

Rockville, MD, US

Overview

1995–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 48 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides29%

A61KPreparations for medical, dental or toiletry purposes28%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%

Y02ATechnologies for adaptation to climate change5%

B65HHandling thin or filamentary material, e.g. sheets, webs, cables1%

C12NMicroorganisms or enzymes1%

G01NInvestigating or analysing materials by determining their chemical or physical properties1%

H01RElectrically-conductive connections1%

H02GInstallation of electric cables or lines, or of combined optical and electric cables or lines1%

H04MTelephonic communication1%

PatentTitleYear

11,098,119Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof2021 11,078,279Combination therapy for the treatment of cancer2021 11,072,653LAG-3-binding molecules and methods of use thereof2021 10,730,947Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof2020 10,717,778Bispecific molecules comprising an HIV-1 envelope targeting arm2020 10,711,069Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcgR2020 10,633,443Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof2020 10,577,422PD-1-binding molecules and methods of use thereof2020 10,160,806Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof2018 9,908,938'Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof'2018 9,708,408'Methods for the treatment of disease using immunoglobulins having Fc Regions with altered affinities for FcÎ³Ractivating and FcÎ³Rinhibiting '2017 9,487,587'Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof'2016 9,056,906'Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity'2015 9,049,782'Mobile device case with retractor reel assembly for user-provided headphones'2015 8,968,730'FcÎ³RIIB specific antibodies and methods of use thereof'2015 8,946,387'FcÎ³RIIB specific antibodies and methods of use thereof'2015 8,800,907'Mobile device case with retractor reel assembly for user-provided headphones'2014 8,663,634'Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity'2014 8,652,466'Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcÎ³Ractivating and FcÎ³Rinhibiting'2014 8,530,627'FcÎ³RIIB specific antibodies and methods of use thereof'2013 8,216,574'Engineering Fc antibody regions to confer effector function'2012 8,193,318'FcÎ³RIIB specific antibodies and methods of use thereof'2012 8,187,593'FcÎ³RIIB specific antibodies and methods of use thereof'2012 8,044,180'FcÎ³RIIB specific antibodies and methods of use thereof'2011 7,847,082'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'2010 7,635,568'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'2009 7,553,489'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'2009 7,504,107'Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response'2009 7,479,282'Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof'2009 7,435,421'Derivatives of choline binding proteins for vaccines'2008 7,425,619'FcÎ³RIIB specific antibodies and methods of use thereof'2008 7,425,620'FcÎ³RIIB-specific antibodies and methods of use thereof'2008 7,323,172'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'2008 7,309,490'Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response'2007 7,229,619'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'2007 7,179,900'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'2007 6,962,701'Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response'2005 6,863,893'Derivatives of choline binding proteins for vaccines'2005 6,858,706'Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof'2005 6,855,493'Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment'2005 6,833,356'Pneumococcal protein homologs and fragments for vaccines'2004 6,818,216'Anti-RSV antibodies'2004 6,689,369'Immunogenic pneumococcal protein and vaccine compositions thereof'2004 6,565,849'Methods of enhancing activity of vaccines and vaccine compositions'2003 6,503,511'Derivatives of choline binding proteins for vaccines'2003 6,368,599'Caulobacter LPS immunoadjuvants'2002 6,280,667'Process for making thermoplastic-biofiber composite materials and articles including a poly(vinylchloride) component'2001 5,454,566'Skelly game'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995Based in Stewart Manor, NY, US· patent location history

2001Based in Stillwater, MN, US· patent location history

2002–2021Based in Rockville, MD, US· patent location history

2003–2008Patents assigned to MEDIMMUNE INC (14)· patent assignee history

2008–2021Patents assigned to MACROGENICS INC (23)· patent assignee history

2008–2015Patents assigned to KOENIG SCOTT (12)· patent assignee history

2008–2015Patents assigned to VERI MARIA CONCETTA (6)· patent assignee history

2012–2015Patents assigned to BONVINI EZIO (5)· patent assignee history

2014–2015Based in Brooklyn, NY, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MACROGENICS INC	23	2008–2021
MEDIMMUNE INC	14	2003–2008
KOENIG SCOTTself	12	2008–2015
VERI MARIA CONCETTA	6	2008–2015
BONVINI EZIO	5	2012–2015

Locations

Location	Patents	Span
Rockville, Maryland, US	44	2002–2021
Brooklyn, New York, US	2	2014–2015
Stillwater, Minnesota, US	1	2001
Stewart Manor, New York, US	1	1995